Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.
Henry K, Katzenstein D, Cherng DW, Valdez H, Powderly W, Vargas MB, Jahed NC, Jacobson JM, Myers LS, Schmitz JL, Winters M, Tebas P; A5102 Study Team of the AIDS Clinical Trials Group. Henry K, et al. J Acquir Immune Defic Syndr. 2006 Jun;42(2):140-8. doi: 10.1097/01.qai.0000225319.59652.1e. J Acquir Immune Defic Syndr. 2006. PMID: 16760795 Clinical Trial.
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Baker JV, et al. Among authors: henry k. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6. doi: 10.1097/QAI.0b013e31817bebb3. J Acquir Immune Defic Syndr. 2008. PMID: 18645520 Free PMC article.
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
Vezina HE, Henry K, Ravindran GD, Kurpad AV, Raj TD, Fox K, Weller D, Brundage RC, Cavert W, Balfour HH Jr. Vezina HE, et al. Among authors: henry k. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):131-6. doi: 10.1097/01.qai.0000199098.95967.ab. J Acquir Immune Defic Syndr. 2006. PMID: 16394842 Clinical Trial.
Untreated HIV infection and large and small artery elasticity.
Baker JV, Duprez D, Rapkin J, Hullsiek KH, Quick H, Grimm R, Neaton JD, Henry K. Baker JV, et al. Among authors: henry k. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):25-31. doi: 10.1097/qai.0b013e3181b02e6a. J Acquir Immune Defic Syndr. 2009. PMID: 19731451 Free PMC article.
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
Henry K, Erice A, Tierney C, Balfour HH Jr, Fischl MA, Kmack A, Liou SH, Kenton A, Hirsch MS, Phair J, Martinez A, Kahn JO. Henry K, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):339-49. doi: 10.1097/00042560-199812010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9833742 Clinical Trial.
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection.
Zhang ZQ, Notermans DW, Sedgewick G, Cavert W, Wietgrefe S, Zupancic M, Gebhard K, Henry K, Boies L, Chen Z, Jenkins M, Mills R, McDade H, Goodwin C, Schuwirth CM, Danner SA, Haase AT. Zhang ZQ, et al. Among authors: henry k. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1154-9. doi: 10.1073/pnas.95.3.1154. Proc Natl Acad Sci U S A. 1998. PMID: 9448301 Free PMC article.
1,107 results